Literature DB >> 31624909

Comparative in vitro activity of bacteriophage endolysin HY-133 against Staphylococcus aureus attached to vascular graft surface.

Evgeny A Idelevich1, Dennis Knaack1, Nyityasmono Tri Nugroho2, Georg Peters1, Theodosios Bisdas3, Sonja Molinaro4, Giovanni B Torsello3, Karsten Becker1, Monika Herten5,6.   

Abstract

Novel strategies are needed for combating Staphylococcus aureus biofilm in vascular graft infections. We investigated the in vitro activity of bacteriophage endolysin HY-133, daptomycin and rifampin against S. aureus attached to vascular graft surface. Daptomycin showed rapid bactericidal effect on surface-associated S. aureus, while the activity of HY-133 on graft surface-adherent cells was moderate and rifampin did not achieve bactericidal effect. Even in the highest concentrations, all antimicrobials used failed in a complete eradication of the surface-adherent bacteria.

Entities:  

Keywords:  Antibiotics; Bacteriophage endolysin; Biofilm; HY-133; Resistance; Staphylococcus aureus

Mesh：

Substances：

Year:  2019        PMID： 31624909     DOI： 10.1007/s00430-019-00638-1

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  29 in total

1.  Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.

Authors:  Raphael Saginur; Melissa Stdenis; Wendy Ferris; Shawn D Aaron; Francis Chan; Craig Lee; Karam Ramotar
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Prevention of vascular graft infections with antibiotic graft impregnation prior to implantation: in vitro comparison between daptomycin, rifampin and nebacetin.

Authors:  T Bisdas; E Beckmann; G Marsch; K Burgwitz; M Wilhelmi; C Kuehn; A Haverich; O E Teebken
Journal:  Eur J Vasc Endovasc Surg       Date:  2012-01-20       Impact factor: 7.069

3.  Management and Outcome of Prosthetic Vascular Graft Infections: A Single Center Experience.

Authors:  Maxime Elens; Muzhakkir Dusoruth; Parla Astarci; Stefano Mastrobuoni; Michel J Bosiers; Jane Nardella; Valérie Lacroix; Julien Possoz; Robert Verhelst
Journal:  Vasc Endovascular Surg       Date:  2018-02-08       Impact factor: 1.089

4.  Vascular Graft Infection: Incidence and Potential Risk Factors.

Authors:  Catherine R Ratliff; David Strider; Tanya Flohr; Danielle Moses; Virginia Rovnyak; Julie Armatas; Jennifer Johnson; Alison Okerlund; Mary Baldwin; Marian Lawson; Suzanne Fuhrmeister; Margaret C Tracci; Gilbert R Upchurch; Kenneth J Cherry
Journal:  J Wound Ostomy Continence Nurs       Date:  2017 Nov/Dec       Impact factor: 1.741

5.  Rifampicin fails to eradicate mature biofilm formed by methicillin-resistant Staphylococcus aureus.

Authors:  Keli Cristine Reiter; Gustavo Enck Sambrano; Bárbara Villa; Thiago Galvão da Silva Paim; Caio Fernando de Oliveira; Pedro Alves d'Azevedo
Journal:  Rev Soc Bras Med Trop       Date:  2012 Jul-Aug       Impact factor: 1.581

Review 6.  Antibiotic-impregnated grafts for aortic reconstruction.

Authors:  Wesley Lew; Wesley Moore
Journal:  Semin Vasc Surg       Date:  2011-12       Impact factor: 1.000

7.  In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results.

Authors:  G Torsello; W Sandmann; A Gehrt; R M Jungblut
Journal:  J Vasc Surg       Date:  1993-04       Impact factor: 4.268

8.  Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.

Authors:  Karen Smith; Ana Perez; Gordon Ramage; Curtis G Gemmell; Sue Lang
Journal:  Int J Antimicrob Agents       Date:  2008-12-19       Impact factor: 5.283

9.  Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in In Vitro Static and Dynamic Models.

Authors:  Wafi Siala; Hector Rodriguez-Villalobos; Prabhavathi Fernandes; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

10.  Rapid in Vitro Quantification of S. aureus Biofilms on Vascular Graft Surfaces.

Authors:  Monika Herten; Theodosios Bisdas; Dennis Knaack; Karsten Becker; Nani Osada; Giovanni B Torsello; Evgeny A Idelevich
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640
View more
  4 in total

Review 1.  Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future.

Authors:  Cheng Chang; Xinbo Yu; Wennan Guo; Chaoyi Guo; Xiaokui Guo; Qingtian Li; Yongzhang Zhu
Journal:  Front Microbiol       Date:  2022-04-04       Impact factor: 6.064

Review 2.  The Advantages and Challenges of Using Endolysins in a Clinical Setting.

Authors:  Ellen Murray; Lorraine A Draper; R Paul Ross; Colin Hill
Journal:  Viruses       Date:  2021-04-15       Impact factor: 5.048

3.  Exploration of Bacterial Re-Growth as In Vitro Phenomenon Affecting Methods for Analysis of the Antimicrobial Activity of Chimeric Bacteriophage Endolysins.

Authors:  Ursula Kaspar; Nina Schleimer; Evgeny A Idelevich; Sonja Molinaro; Karsten Becker
Journal:  Microorganisms       Date:  2022-02-15

4.  Comparison of Enterococcus faecalis Biofilm Removal Efficiency among Bacteriophage PBEF129, Its Endolysin, and Cefotaxime.

Authors:  Hyun Keun Oh; Yoon Jung Hwang; Hye Won Hong; Heejoon Myung
Journal:  Viruses       Date:  2021-03-07       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.